DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Blastoma
Blastoma
The Retinoblastoma Tumor-Suppressor Gene, the Exception That Proves the Rule
Central Nervous System Cancers Panel Members Can Be Found on Page 1151
Inhibitors of Mammalian Target of Rapamycin Downregulate MYCN Protein Expression and Inhibit Neuroblastoma Growth in Vitro and in Vivo
1P36 Tumor Suppression—A Matter of Dosage?
Retinoblastoma
The Functional Loss of the Retinoblastoma Tumour Suppressor
Carcinogenesis and Chemotherapy—Cancer's Continuing Core Challenges: Third Charles Heidelberger Symposium1
Screening for Pineal Trilateral Retinoblastoma Revisited a Meta-Analysis
Iron Chelation Inhibits Mtorc1 Signaling Involving Activation of AMPK and REDD1/Bnip3 Pathways
Combined Mtorc1/Mtorc2 Inhibition Blocks Growth and Induces Catastrophic Macropinocytosis in Cancer Cells
The Answer Cancer?
Oncogenic Activation of FOXR1 by 11Q23 Intrachromosomal Deletion-Fusions in Neuroblastoma
Cancer: a Small Review
Differential Diagnosis of Neuroblastoma and Burkitt's Tumour
Primary Brain Tumors in Adults Sreenivasa R
Inhibiting 4EBP1 in Glioblastoma Qi Wen Fan1,2, Theodore P
The Neuroblastoma and Ganglion Components of Nodular
Understanding Cancer Stem Cell Heterogeneity and Plasticity
Top View
Surgical and Non-Surgical Management and Treatment of Glioblastoma: I
Birth Defects and Cancer: the Intersection of Genes and Prenatal Exposures, September 10–11, 2012
Retinoblastoma?
Neuroblastoma Presenting As Central Nervous System Disease
Primary Brain Tumors
Age and Susceptibility Jerry M
Precision Cancer Therapy Is Impacted by Oncogene-Dependent Epigenome Remodeling
WHO Revised Classification of Tumors of the Central Nervous
Neuroblastoma Therapy: What Is in the Pipeline?
Human Cancers by Organ Site
Understanding Prb: Toward the Necessary Development of Targeted Treatments for Retinoblastoma Uma M
Carcinogenic Risk Factors
Diagnosis and Current Management of Retinoblastoma
CLIC1 and CLIC4 Complement CA125 As a Diagnostic Biomarker Panel For
The N-Myc Oncogene: Maximizing Its Targets, Regulation, and Therapeutic Potential
Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies
Neuroblastoma: Biology, Prognosis, and Treatment Julie R
PLEUROPULMONARY BLASTOMA: a CASE REPORT Blastoma Pleuropulmonar: Presentación De Un Caso
Classic Biphasic Pulmonary Blastoma: Importance of Early Treatment—A Case Report
Identification of WISP1 As a Novel Oncogene in Glioblastoma
Cancer.Org | 1.800.227.2345
Safe and Effective Treatment of Experimental Neuroblastoma And
The Tyrosine Phosphatase PTPRD Is a Tumor Suppressor That Is Frequently Inactivated and Mutated in Glioblastoma and Other Human Cancers